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Abstract
Background Few large series of hard bearing surfaces
have reported on reasons for early failure. A number of
unique mechanisms of failure, including fracture, squeak-
ing, and adverse tissue reactions, have been reported with
these hard bearing surfaces. However, the incidence varies
among the published studies.
Questions/purposes To confirm the incidences, we iden-
tified the etiologies of early failures of hard-on-hard
bearing surfaces for ceramic-on-ceramic and metal-on-
metal THAs.
Methods We retrospectively reviewed records of 2907
THAs with hard-on-hard bearing surfaces implanted
between 1996 and 2009; 1697 (58%) had ceramic-on-
ceramic and 1210 (42%) had metal-on-metal bearing sur-
faces. We recorded bearing-related complications and
compared them to nonspecific reasons for revision THA.
The minimum followup of the ceramic-on-ceramic and
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metal-on-metal cohorts was 6 months (mean, 48 months;
range, 6–97 months) and 24 months (mean, 60 months;
range, 24–178 months), respectively.
Results The overall revision rate for ceramic-on-ceramic
THA was 2.2% (38 of 1697), with aseptic loosening
accounting for 55% of revisions (femur or acetabulum).
The bearing accounted for 13% of the revisions in the
ceramic-on-ceramic THA cohort. The overall metal-on-
metal revision rate was 5.4% (65 of 1210), 17 involving
adverse tissue reactions related to the metal-on-metal
bearing surface (17 of 1210, 1.4% of cases; 17 of 65, 26%
of revisions).
Conclusions Twenty-six percent of the revisions from
metal-on-metal and 13% of ceramic-on ceramic were
bearing related. The overall short- to medium-term revision
rate was 2.2% and 5.4% for ceramic-on-ceramic and metal-
on-metal, respectively. The most common etiology of fail-
ure was loosening of the femoral or acetabular components.
Level of Evidence Level IV, therapeutic study. See the
Guidelines for Authors for a complete description of level
of evidence.
Introduction
Hard-on-hard bearings (metal-on-metal [MOM] and ceramic-
on-ceramic [COC]) have been increasingly utilized in the
past decade in an attempt to improve the long-term results of
THA [1]. One presumed advantage is lower wear rate and
debris generation from the articulating surface. Wear rates of
MOM and COC hip prostheses reportedly have two to three
times less volumetric wear than metal-on-polyethylene
(MOP) when tested in laboratory settings [5]. MOM articu-
lations allow for larger head-neck ratios than current options
for MOP, which allows for a larger ROM before impinge-
ment and stability [31]. Recent studies demonstrated larger-
diameter metal heads decreased dislocation rates to as low
as 0.05% and were able to better approximate anatomic
femoral heads in primary arthroplasty [21], while other
studies found a higher rate of revision for dislocation, up to
0.8% in hard-on-hard THA, particularly with the use of
smaller head sizes [26].
Both hard-on-hard bearing options were developed and
used before the short- to medium-term results of highly
crosslinked polyethylene were reported. The wear rate of
highly crosslinked polyethylene is 23%–95% lower than
conventional polyethylene [3, 4, 13], even for thinner liners,
allowing for use of larger femoral heads, neutralizing the
purported advantages of the hard bearings to a degree.
However, these data emerged over time, as hard bearings
became available in the marketplace and grew rapidly,
peaking to about 40% use during THA by 2006 [1].
Since then, concerns with use of hard-on-hard bearing
surfaces in THA have steadily increased [2] due to unique
complications reported with varying frequency. For
ceramics, the major unique complications are fracture and
noise generation (squeaking). For metals, the major con-
cerns are adverse tissue reactions of various descriptions
and, to a lesser degree, failure of ingrowth or early loos-
ening of components. Various authors reported the
frequency of fracture of contemporary devices between
0.004% and 0.19% [27, 30, 31] and squeaking between 1%
and 21% [3, 16, 28]. The incidence of major tissue reac-
tions is unknown currently, but some believe it to be
around 1% or less [2] and that of early loosening to be
between 1% and 6% [11]. However, the incidence of these
complications leading to revision arthroplasty is not well
established by prior literature.
We therefore determined (1) the rates of revision for
current COC and MOM THA and (2) the reasons for
revision compared to published reports.
Patients and Methods
We retrospectively reviewed 2869 patients who had 3346
THAs with hard-on-hard bearing surfaces implanted
between January 1996 and March 2009; 1757 (53%) were
COC components and 1589 (47%) were MOM components
(Table 1). During that time, we treated 13,073 patients,
between two institutions, with THA using all implants. The
indications for the use of a hard-on-hard bearing surface
were (1) patients with end-stage arthritis, (2) active patients,
(3) patients younger than 60 years, and (4) patients at high
risk for instability (MOM cohort). The contraindications for
surgery were patients with (1) infection, (2) severe bone loss,
(3) compromised soft tissue envelope, (4) neurovascular
deficiency, and (5) preexisting conditions prohibiting
induction of anesthesia. The average age of the patients in
the COC cohort was 50 years (range, 15–80 years), with
1017 patients (60%) being men. The mean height and weight
of this cohort were 1.7 m (range, 1.2–2.2 m) and 100 kg
(range, 37.2–214.5 kg), respectively. The average age of the
patients in the MOM cohort was 58 years (range, 19–
89 years), with 628 (52%) patients being men. The mean
height and weight in this cohort were 1.7 m (range, 1.2–
1.9 m) and 92.5 kg (range, 45.5–205 kg), respectively. No
patients were recalled specifically for this study; all data
were obtained from medical records and radiographs. We
had prior Institutional Review Board permission.
For the COC cohort, we used one of six different
acetabular shell types between 2002 and 2009, with the
two most common types being Trident1 PSL1 (806 of
1757 patients, 45%) and Trident1 Hemispherical1 (692
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of 1757, 39%) (Stryker Orthopaedics, Mahwah, NJ, USA).
Between 2002 and 2009, we used 10 types of femoral
stems, with the most common being Accolade1 (1338 of
1757 patients, 76%) (Stryker Orthopaedics). Femoral head
sizes ranged from 28 to 36 mm. Minimum followup was
6 months (mean, 50.4 months; range, 6–96 months) in the
COC cohort, with 1697 records (97%) available. Six
different surgeons performed the procedures, each utiliz-
ing a modified Hardinge approach [10] while the patient
was in a supine position. Patients in the COC cohort
returned for followup visits at 6 weeks, 6 months, and
1 year. Afterwards, we followed up with patients at either
1- or 2-year intervals to assess for component failure. At
each postoperative visit, the surgeons evaluated patients
and obtained radiographs. Sixty patients from the COC
cohort were lost to followup at an average of 65 days
(range, 0–179 days).
Between 1996 and 2006, the surgeons at one center
performed 1589 MOM primary THAs, of which a mini-
mum 2-year followup (mean, 60.2 months; range, 24–
178 months) was available for 1210 (76%). The surgeons
utilized three systems of acetabular construct: a modular
titanium shell with a CoCr insert and a 28- or 32-mm inner
diameter (351 patients, 22%), a CoCr monoblock shell of
increasing thickness mated with a 38-mm CoCr head (750,
47%), and a solid ‘‘resurfacing style’’ CoCr monoblock
thin (3-mm) shell with anatomic heads of increasing
diameter (40–60 mm) (488, 31%). Four surgeons per-
formed the procedures, all utilizing a modified direct lateral
approach (modified Hardinge) with the patient in the lateral
decubitus position. Patients were followed at 6 weeks and
then seen yearly thereafter. At each postoperative visit, the
surgeons evaluated patients and obtained radiographs.
Three hundred seventy-nine patients from the MOM cohort
were lost to followup at an average of 234 days (range, 3–
690 days). From the medical records, we determined
whether the patient had a revision and those lost to
followup.
We used a two-tailed unpaired t-test to assess differ-
ences in continuous variables (age, height, weight, BMI)
and a two-tailed Fisher exact test to determine differences
in sex proportions between revised and unrevised hips. We
used a univariate regression analysis for the MOM design
type data. We analyzed all data using SPSS1 (SPSS Inc,
Chicago, IL, USA).
Results
Of 1697 patients with COC THAs, 38 (2.2%) had revision
THA (Table 1). The mean age of these 38 patients was
45 years, which was younger (p = 0.001) than the rest of
the cohort at a mean of 50 years. There was no difference
(p = 0.939) between the percent of men (23 of 38, 61%)
and women (15 of 38, 39%) in the COC revision group.
The average weight (97.5 kg) (p = 0.027) and BMI
(31.8 kg/m2) (p = 0.016) were higher in the revision
group. The most common reason for revision was aseptic
loosening (Table 2). The stem was loose in 10 patients, the
cup in eight, and both in three, with an overall failure of
fixation rate of 1.2% or 55% of the revisions (21 of 38).
Five cases (0.2% overall; 13% of revisions) were perceived
to be related to the bearing surface or design of the com-
ponents (squeaking, four; fracture, one), and 10 cases were
revised for impingement and/or subluxation potentially
attributable to surgeon-related positioning of the compo-
nents (impingement, subluxation; 0.6% overall, 26% of
revisions). Average time to revision was 25.7 months.
Sixty-five of the 1210 MOM THAs (5.4%) underwent
revision (Table 1), of which 17 were due to adverse tissue
reactions related to the MOM implant (17 of 1210, 1.4% of
cases overall; 17 of 65, 26% of revisions) (Table 3). The
Table 1. Summary of results of COC and MOM THA
Demographic variable COC Revised Nonrevised p value MOM Revised Nonrevised p value
Total number of THAs 1757 1589
MOM Group 1 351 12 339 \ 0.001
MOM Group 2 750 41 709 \ 0.001
MOM Group 3 488 12 476 0.166
Number of THAs
with followup
1697
(98%)
1210
(76%)
Male 1017 23 994 0.939 628 17 611
Female 680 15 665 582 48 534 \ 0.001
Age (years) 50 45 50 0.001 58 56 58 0.206
Height (m) 1.7 1.7 1.7 0.773 1.7 1.7 1.7 0.009
Weight (kg) 100 97.5 85.6 0.027 92.5 89.9 92.7 0.355
BMI (kg/m2) 35 31.8 28.4 0.016 31.4 31.9 31.3 0.575
COM = ceramic-on-ceramic; MOM = metal-on-metal.
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most common cause of revision was aseptic loosening,
which occurred in 32 cases (32 of 1210, 2.6% overall; 32 of
64, 50% of revisions). The incidence of revision was higher
in women (p \ 0.001) and for the second type of compo-
nent (38-mm inner diameter, solid, CoCr shell) (p \ 0.001)
(Table 1). In addition, the revision procedures were asso-
ciated with substantial tissue damage, a compromised
clinical result after revision, and a higher than expected
revision rate.
Discussion
During the past decade, various studies have reported
outcomes and survival of alternative bearing surfaces in
THA [6, 7, 9, 12, 14, 15, 19, 20, 23–25]. Complications
associated with the use of hard-on-hard bearings include
squeaking, fracture, liner disassociation, metallosis, and
hypersensitivity reactions occurring in some patients [14].
However, the incidence of these complications leading to
revision arthroplasty is not well established by prior liter-
ature. We therefore determined (1) the rates of revision for
current COC and MOM THA and (2) the reasons for
revision compared to published reports.
This study had several limitations. First, our study
population was from two joint arthroplasty centers and did
not represent the general population, as hard-on-hard
bearings are more likely to be used in younger patients who
need THA. The surgeons most likely selected patients with
high levels of activity to receive hard-on-hard bearings, the
current indication for the use of these bearing surfaces.
Thus, we could not match these patients for age and
activity level with a cohort receiving other bearing surface
to conduct a comparative analysis. Second, a variety of
Table 2. Reported survival rates and complications of ceramic-on-ceramic THA
Study Number
of hips
Followup
(months)*
Survival
(%)
Level of
evidence
Reported complications
Lombardi et al. [20] 65 73 (26–108) 95 II Aseptic loosening (1); fracture (1); infection (1)
Hamilton et al. [9] 177 31 (21–49) 98 I Aseptic Loosening (2); dislocation (2); fracture (1);
infection (3)
Petsatodis et al. [25] 85 252 84 IV Aseptic loosening of cup (6); aseptic loosening of stem (1)
Lee et al. [18] 88 130 (120–142) 97 IV Fracture (2); noise/squeak (13); impingement/fretting (6);
periprosthetic fracture (1); dislocation (1)
Lewis et al. [19] 56 100 (58–121) 97 I Dislocation (1); pain unknown (1)
Capello et al. [3] 380 96 96 I Fracture (2); squeak (3); psoas tendinitis (1); infection (3);
periprosthetic fracture (1); aseptic loosening (1)
Iwakiri et al. [12] 82 80 (60–100) 91 IV Fracture (3); dissociation (1); infection (2); dislocation (1);
fretting/impingement (1)
Current study 1697 50 (6–96) 98 IV Infection (1); aseptic loosening of cup (8); aseptic loosening
of femur (10); aseptic loosening of both cup and
femur (3); squeaking (4); fracture (1); liner
(impingement, subluxation, wear) (11)
* Values are expressed as mean, with range in parentheses.
Table 3. Reported survival rates and complications of metal-on-metal THA
Study Number
of hips
Followup
(months)*
Survival
(%)
Level of
evidence
Reported complications
Dastane et al. [6] 112 66 (26–140) 99 III Aseptic loosening (1); dislocation (2); impingement (2);
dissociation (1); periprosthetic fracture (1)
Jacobs et al. [15] 95 40 (36–68) 99 I Dislocation (1); aseptic loosening (1)
Neumann et al. [24] 100 126 (120–143) 94 IV Aseptic loosening (4); periprosthetic fracture (1);
mechanical failure (1)
Korovessis et al. [17] 217 77 (6–112) 93 IV Aseptic loosening (10); infection (3); dislocation (1)
Milosev et al. [23] 640 85 (28–126) 93 IV Infection (6); aseptic loosening (25); dislocation (1);
fracture (1); dissociation (1)
Dorr et al. [7] 70 60 (48–84) 98 IV Aseptic loosening (1); dislocation (2); infection (1)
Current study 1215 60 (24–178) 95 IV Infection (10); aseptic loosening (32); metallosis/
hypersensitivity (17); dislocation (1); cup well fixed (5)
* Values are expressed as mean, with range in parentheses.
Volume 470, Number 2, February 2012 Revision of Failed Hard-on-Hard THA 385
123
devices were utilized, including different femoral stems
and acetabular components, as well as different varieties of
COC and MOM bearing surfaces. Hence, the failure of
THA in this cohort was due to a multitude of reasons, most
of which related to prosthetic devices, and not all failures
occurred because of the bearing surface. Third, many sur-
geons contributed patients, with the potential that each
surgeon performed the procedure differently. We had no
standard protocol for performing the THA and the use of
hard-on-hard bearing surfaces. Fourth, despite having a
digital database that minimizes errors in place at both
institutions, the retrospective character of our study in
which recollection of data may be inaccurate. Some of the
patients in one or both institutions may have sought eval-
uation and treatment for possible complications elsewhere.
Fifth, while the overall cohort was relatively large, the
subcohorts were too small to perform a multivariable
analysis to determine differences in the groups while
controlling for potentially confounding variables.
A review of recent COC outcomes demonstrated survival
rates of 84%–98% [9, 25] (Table 2). Our data support these
findings with a survival rate of 98%. The etiologies for
revision varied depending on the study and length of fol-
lowup. In our analysis, the most common reason for
revision THA was not bearing related, which was consistent
with the previous studies reporting outcomes of COC THA.
A review of recent literature reporting outcome of MOM
THA demonstrated an overall survival rate between 93%
and 99% [6, 23] (Table 3). The failure rate of MOM THA in
our cohort (5%) was similar to these previous reports. The
majority of the studies reported aseptic loosening as the
most common cause of revision for the MOM THA, again
consistent with the outcomes of our study [17, 23].
We found only 13% of failures of COC THA were
potentially attributable to bearing surface, and the majority
of failures in this cohort were acetabular or femoral com-
ponent related. We found squeaking and fracture were the
most common bearing surface-related complications. The
etiology of impingement was not clear in all cases but
believed to have occurred as a result of excessive ante-
version of the acetabular component in patients with
elevated ceramic acetabular liner. Impingement may be an
important contributor to wear of any bearing surface if
components are malpositioned and several recent articles
have specifically discussed accelerated wear with the use of
COC bearing surfaces [8, 29]. Hence, failure to recognize
malpositioning of acetabular components could have
accelerated failure for all bearings, despite improved wear
rates of hard-on-hard compared to metal on polyethylene.
The results from the MOM cohort demonstrated the use of
the hard bearing surfaces attributed to 26% of revisions.
The use of MOP could have helped to avoid adverse tissue
reactions requiring revision surgery. Studies have reported
failures with specific MOM designs, and surgeons should
consider these before implantation and widespread use
[22]. Despite the revisions attributed to hard-on-hard
bearings, the data highlight the initial workup of a failed
hard-on-hard bearing should mirror that of MOP. Infection,
aseptic loosening, component malposition, and recurrent
dislocation all are potential reasons for failure of THA and
should be investigated before attributing the failure to the
bearing surface alone.
Despite the complications due to the use of hard-on-hard
bearing surfaces, the overall short-term revision rates in our
study were 2.2% for COC and 5.4% for MOM. These rates
were consistent with other studies documenting similar
success with the use of alternative bearings [18, 31]. Our
study retrospectively reviewed a combined 2869 patients
who underwent hard-on-hard THA. We had 439 patients
between both cohorts lost to followup.
We reviewed the complications and revisions associated
with the use of hard-on-hard bearings, and despite docu-
mented, successful, short-term outcomes, we believe the
data do not warrant the widespread use of alternative
bearings and replacement of traditional MOP. Because of
these results and other ongoing concerns, improvements in
hard-on-hard bearing technology continues, and surgeons
should reserve current implementation for as-yet-undefined
patient populations in need of THA. Despite improvements
in alternative bearing choices for THA, early failures due
to impingement and wear can still result from technical
error and malpositioning. Metal-on-highly crosslinked
polyethylene has demonstrated encouraging results in
short- to medium-term studies, although the long-term
implications of free radicals using this bearing surface are
still unknown. Which bearing surface demonstrates supe-
rior long-term outcomes has yet to be resolved, and thus
more long-term studies are needed to formulate a decision.
Surgeons should counsel possible candidates for alternative
bearings on the potential complications associated with
their use, including but not limited to squeaking, implant
failure, and soft tissue reaction. Based on our findings, we
believe surgeons should be guarded when considering the
use of current MOM technology in female patients. It is our
opinion that, as with many new advancements in technology,
one should temper early aggressive enthusiasm and wide-
spread implementation with review of long-term studies and
scrutiny of complications that may arise with its use.
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